from Nova Leah

SelectEvidence® from Nova Leah automates cybersecurity risk management for connected medical devices.
  • Detailed product demo.
  • No credit card required. No strings.
  • Obligation free walk-through. 
  • Free five day evaluation available.
Book your demo today


Technology Ireland Awards | Ibec
Emerging Company of the Year -2019

High Potential Exporter Award
Export Industry Awards  Winner 2019

KTI Impact Awards 2019
Spin-out Company Award Winner 2019

Centralized cybersecurity risk management

SelectEvidence® from Nova Leah allows manufacturers of connected medical devices to automate the process of conducting premarket and postmarket cybersecurity risk assessments for entire product portfolios.
SelectEvidence® breakdown:

  • Risk assessment platform.
  • sBoM ingestion.
  • Continuous vulnerability monitoring.
  • Automated MDF2 generation.
  • Risk analysis decision support.
  • Threat modelling.
  • FDA premarket and postmarket cybersecurity compliance.

“A specialist in cybersecurity for medical devices”

“A specialist in cybersecurity for medical devices, its platform SelectEvidence® helps medical device providers to monitor defibrillators, pacemakers and insulin pumps connected to wireless networks, to ensure they are safe and can deal with potential threats.”

WIRED Magazine, Listing Europe’s 100 Hottest Startups 2019

Simple and straightforward trial process

30 minute product demo

Detailed run-through

We provide all prospective users with a detailed product demo. We demonstrate how SelectEvidence® saves time and automates cybersecurity risk management.

Free five-day evaluation

Mapped to your own success criteria

Demos are followed by a free, five-day evaluation where MDMs discover how SelectEvidence® integrates seamlessly into their product development lifecycle.

Connect and review

Outlining clear integration pathways

Upon successful completion of the first two stages, we reconnect with all stakeholders and decision-makers to put a clear integration plan in place.

Ready to get started?


Request a free demo to see how SelectEvidence® helps effortlessly integrate
cybersecurity processes into your system development life cycle.

Book your demo today

Leadership team

Anita Finnegan


Anita founded Nova Leah and is the Author and International Project Leader of IEC 80001-2-8 and IEC 80001-2-9. As an internationally recognized expert in Medical Device Cybersecurity she also has a strong background in software quality processes, engineering and quality engineering roles across multiple highly regulated domains. Anita’s PhD research focused on medical device cybersecurity assurance cases.

Peter Finnegan


Peter brings over 30 years’ experience in the global healthcare and pharmaceutical business to Nova Leah. Peters expertise culminated over 28 years of senior management leadership.

Fergal McCaffery

Co-founder / Head of Engineering

Fergal is internationally recognized for his contributions to medical device software engineering. His research team have led the development of 4 International Standards/Technical reports for medical device software. He was also the Leader for the development of IEC/TR 80002-3 for medical device software processes in collaboration with the ISO/IEC 62304 development team. Fergal is also Senior Lecturer in the Department of Computing and Mathematics, in Dundalk Institute of Technology (DkIT).

Request your free demo


One of our team will be in touch, to schedule your demo of SelectEvidence the award winning software from Nova Leah.

About Nova Leah

Nova Leah is a world leader in centralized risk management systems. Our solutions, designed by industry experts, provide complete oversight of medical device vulnerabilities and threats, and automate the management and mitigation of risk.

Join our team: We Are Hiring!

Site Links



P: +353 42 93 43 0 33
Block 3, Finnabair Business &
Technology Park, Dundalk, Co Louth, Ireland A91 XR61

P: +1 617 314 7010
6th Floor, 399 Boylston Street,
Boston, MA 02116,
United States

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google